Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.21.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]  
Schedule of Diluted Net Loss Per Common Share Diluted net loss per common share for the three and six months ended June 30, 2021 and 2020 was determined as follows (in thousands, except share and per share amounts):

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Net income (loss)

$

1,658

 

 

$

(6,381

)

 

$

(3,018

)

 

$

(13,383

)

Dilutive effect of warrant liability

 

(7,415

)

 

 

 

 

 

(8,739

)

 

 

 

Net loss allocated to common shares

$

(5,757

)

 

$

(6,381

)

 

$

(11,757

)

 

$

(13,383

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding – basic

 

26,015,292

 

 

 

10,009,614

 

 

 

25,909,457

 

 

 

9,877,094

 

Dilutive effect of warrant liability

 

472,681

 

 

 

 

 

 

596,351

 

 

 

 

Weighted average common shares outstanding – diluted

 

26,487,973

 

 

 

10,009,614

 

 

 

26,505,808

 

 

 

9,877,094

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share – diluted

$

(0.22

)

 

$

(0.64

)

 

$

(0.44

)

 

$

(1.35

)

 

Summary of Antidilutive Securities Excluded from Computation of Weighted Average Common Stock Outstanding

The following potentially dilutive shares of common stock have not been included in the computation of diluted net loss per share for the three and six months ended June 30, 2021 and 2020, as the result would be anti-dilutive:

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Outstanding stock options

 

1,607,080

 

 

 

781,685

 

 

 

1,607,080

 

 

 

781,685

 

Outstanding restricted stock units

 

134,774

 

 

 

84,929

 

 

 

134,774

 

 

 

84,929

 

Warrants to purchase common stock associated with June 2016 public offering

 

 

 

 

421,867

 

 

 

 

 

 

421,867

 

Warrants to purchase common stock associated with March 2018 public offering – Series 2

 

798,810

 

 

 

798,810

 

 

 

798,810

 

 

 

798,810

 

Warrants to purchase common stock associated with December 2019 Public Offering

 

4,472,205

 

 

 

4,472,205

 

 

 

4,472,205

 

 

 

4,472,205

 

Warrants to purchase common stock associated with December 2020 Public Offering - Series 2

 

6,800,000

 

 

 

 

 

 

6,800,000

 

 

 

 

Warrants to purchase common stock associated with Loan Agreement

 

170,410

 

 

 

 

 

 

170,410

 

 

 

 

Warrants to purchase common stock associated with Solar loan agreement

 

12,243

 

 

 

12,243

 

 

 

12,243

 

 

 

12,243

 

Common stock associated with March 2019 Notes

 

1,138,200

 

 

 

1,138,200

 

 

 

1,138,200

 

 

 

1,138,200

 

Common stock associated with April 2020 Notes

 

 

 

 

1,622,138

 

 

 

 

 

 

1,622,138

 

Total

 

15,133,722

 

 

 

9,332,077

 

 

 

15,133,722

 

 

 

9,332,077